经鼻湿化快速充气通气交换用于喉显微手术的效用
该病例系列回顾了53例以THRIVE作为唯一通气方式行喉显微手术的患者,中位呼吸暂停时间16分钟,中位呼气末CO2为50 mmHg、最低SpO2为95%。6例因持续氧饱和度下降需补充喷射通气或气管插管,呼吸暂停期间呼气末CO2以0.844 mmHg/min的速度上升。作者认为THRIVE在合适选择的患者中是安全有效的,但需备好补救方案。
要点
- THRIVE可作为喉显微非激光手术的唯一通气方式。
- 中位呼吸暂停16分钟,需监测CO2上升与氧饱和度下降。
- 应备好喷射通气或喉显微气管插管等补救方案。
核心结论
- THRIVE是合适选择的患者行喉显微非激光手术时安全有效的氧合与通气技术。
研究设计与样本
- 病例系列(证据等级4),回顾电子病历,纳入53例以THRIVE为唯一通气方式行喉显微手术的患者。
主要发现
- 53例中女性占62%,中位年龄51岁,中位BMI为25 kg/m2,多数为ASA 2级、Mallampati评分2。
- 最常见手术指征为声门下狭窄、声带病变和声带麻痹。
- 中位呼吸暂停时间为16分钟,术末中位呼气末CO2为50 mmHg,中位最低SpO2为95%。
- 6例因持续氧饱和度下降需以喷射通气或气管插管补充THRIVE。
- 呼吸暂停期间呼气末CO2以0.844 mmHg/min的速度上升。
临床怎么用
- 在合适选择的患者中可将THRIVE用于喉显微非激光手术的氧合与通气。
- 术中需监测呼气末CO2与SpO2,并备好喷射通气和喉显微气管插管等补救方案。
局限性
- 研究为病例系列,证据等级4。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Microlaryngeal surgery typically requires oxygenation and ventilation via either an endotracheal tube (ETT), jet ventilation (JV), or intermittent apnea with an ETT. Transnasal Humidified Rapid Insufflation Ventilatory Exchange (THRIVE) delivered by high flow nasal cannula has been reported as an alternative technique. This method of apneic oxygenation and ventilation allows for stable, unobstructed visualization of immobile laryngeal structures. We aim to describe the technique and characterize intraoperative parameters related to its safety. STUDY DESIGN: Case Series. METHODS: The electronic medical record was reviewed for patients who underwent microlaryngoscopy using THRIVE technique. Patient demographics, procedural details, operative parameters, and anesthesia records were reviewed. Descriptive statistics were reported. RESULTS: A total of 53 patients underwent microlaryngoscopy using THRIVE as the sole method of ventilation, with 62% female. Median age was 51 years, and median BMI was 25 kg/m2 . Most patients were ASA class 2, and most had a Mallampati score of 2. The most common surgical indications were subglottic stenosis, vocal fold lesions, and vocal fold paralysis. Median apnea time was 16 minutes. At the end of case, median end tidal CO2 was 50 mmHg, and median minimum SpO2 was 95. Six cases required supplementation of THRIVE with JV or tracheal intubation for sustained oxygen desaturation. There was an increase in end tidal CO2 of 0.844 mmHg/min of apneic time. CONCLUSIONS: THRIVE is a safe and effective technique for oxygenation and ventilation in microlaryngeal, non-laser surgery in appropriately selected patients. To ensure safety, back-up plans such as jet ventilation and microlaryngeal ETT should be available. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:587-591, 2021.
引用
- Benninger MS, Zhang ES, Chen B, et al. Utility of Transnasal Humidified Rapid Insufflation Ventilatory Exchange for Microlaryngeal Surgery. Laryngoscope. 2020. PMID: 32542687. doi:10.1002/lary.28776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。